Back to REGN
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND → REGN
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$30.4M
Q3 2026
Peak value
$30.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $19.8M |
| Q4 2025 | $15.2M |
| Q1 2026 | $23.7M |
| Q2 2026 | $26.7M |
| Q3 2026 | $30.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30.4M | 40.1K | — | — |
| Q2 2026 | $26.7M | 42.7K | — | — |
| Q1 2026 | $23.7M | 30.7K | — | — |
| Q4 2025 | $15.2M | 19.7K | — | — |
| Q3 2025 | $19.8M | 35.3K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B